CARDIAC ARRHYTHMIA AND CONDUCTION DISTURBANCES IN PATIENTS WITH SYSTEMIC SCLEROSIS

Cover Page


Cite item

Full Text

Abstract

Aim: To assess prevalence of certain cardiac arrhythmias and conduction disturbances in the Russian population of systemic sclerosis patients using standard 12-lead and 24-hour electrocardiography (ECG); to estimate correlation between cardiac arrhythmia and clinical features of systemic sclerosis. Materials and methods: 80 systemic sclerosis patients and 60 sex- and age-matched controls were included. All patients underwent standard 12-lead and 24-hour ECG. Results: Arrhythmias on standard 12-lead ECG were demonstrated in 14 patients (17.5%) including sinus arrhythmia in 2 cases and premature beats in 13 cases (16%). Supraventricular (SV) and ventricular (V) ectopic beats were recorded in 5 (6%) and 7 (9%) patients, respectively; in one patient both SV and V ectopic beats were found. ECG signs of focal fibrosis were demonstrated in 9 patients (11%). In 24-hour ECG, frequencies of SV and V ectopic beats were 40 and 65%, respectively. Compared to the controls, systemic sclerosis patients had significantly higher prevalence and severity of cardiac arrhythmia. 36% of patients had high grade ventricular premature beats, associated with potential risk of life-threatening arrhythmia and sudden cardiac death. Conclusion: Cardiac arrhythmias and conduction disturbances are found in the majority of patients with systemic sclerosis. Standard ECG does not reflect true prevalence of cardiac arrhythmia in systemic sclerosis. In systemic sclerosis patients, 24-hour ECG is recommended as obligate method for initial examination and treatment efficacy control.

About the authors

R. T. Alekperov

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation
V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences; 34А Kashirskoe shosse, Moscow, 115522, Russian Federation

Author for correspondence.
Email: ralekperov@list.ru

MD, PhD, Professor, Internal Diseases Department, Postgraduate Medical School;

Senior Research Associate

Россия

E. O. Cheremukhina

Fellow

Email: fake@neicon.ru
V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences; 34А Kashirskoe shosse, Moscow, 115522, Russian Federation Россия

D. S. Novikova

PhD, Senior Research Associate2

Email: fake@neicon.ru
V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences; 34А Kashirskoe shosse, Moscow, 115522, Russian Federation Россия

L. P. Anan’eva

PhD, Professor, Head of Laboratory of Microcirculation and Inflammation

Email: fake@neicon.ru
V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences; 34А Kashirskoe shosse, Moscow, 115522, Russian Federation Россия

References

  1. Гусева НГ. Системная склеродермия и псевдосклеродермические синдромы. М.: Меди-цина; 1993. 300 с. (Guseva NG. Systemic sclerosis and pseudo-scleroderma syndromes. Мoscow: Meditsina; 1993. 300 p. Russian).
  2. Geyer M, Müller-Ladner U. The pathogenesis of systemic sclerosis revisited. Clin Rev Allergy Immunol. 2011;40(2):92–103.
  3. Abu-Shakra M, Lee P. Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol. 1995;22(11):2100–2.
  4. Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol. 1998;37(7):750–5.
  5. Bryan C, Knight C, Black CM, Silman AJ. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum. 1999;42(12):2660–5.
  6. Simeón CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaqué J, Vilardell M. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford). 2003;42(1):71–5.
  7. Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum. 2010;39(4):269–77.
  8. Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am. 2003;29(2):239–54.
  9. Ferri C, Valentini G, Cozzi F, Sebastiani M, Mi-chelassi C, La Montagna G, Bullo A, Cazzato M, Tirri E, Storino F, Giuggioli D, Cuomo G, Rosada M, Bombardieri S, Todesco S, Tirri G; Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002;81(2):139–53.
  10. Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med. 1971;75(3):369–76.
  11. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, Kuwana M, Yasuoka H, van den Hoogen F, Te Boome L, van Laar JM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005;118(1):2–10.
  12. Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis. 2010;103(1):46–52.
  13. Desai CS, Lee DC, Shah SJ. Systemic sclerosis and the heart: current diagnosis and management. Curr Opin Rheumatol. 2011;23(6): 545–54.
  14. Marasini B, Massarotti M, Cossutta R. Scleroderma heart disease. Int J Immunopathol Pharmacol. 2005;18(4):609–14.
  15. Seferović PM, Ristić AD, Maksimović R, Simeunović DS, Ristić GG, Radovanović G, Seferović D, Maisch B, Matucci-Cerinic M. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford). 2006;45 Suppl 4:iv39–42.
  16. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation. 1976;53(3):483–90.
  17. Follansbee WP, Curtiss EI, Rahko PS, Medsger TA Jr, Lavine SJ, Owens GR, Steen VD. The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature. Am J Med. 1985;79(2):183–92.
  18. Morelli S, Sgreccia A, Ferrante L, Barbieri C, Bernardo ML, Perrone C, De Marzio P. Relationships between electrocardiographic and echo-cardiographic findings in systemic sclerosis (scleroderma). Int J Cardiol. 1996;57(2):151–60.
  19. Assassi S, Del Junco D, Sutter K, McNearney TA, Reveille JD, Karnavas A, Gourh P, Es-trada-Y-Martin RM, Fischbach M, Arnett FC, Mayes MD. Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum. 2009;61(10):1403–11.
  20. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23(5):581–90.
  21. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–5.
  22. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971;44(1):130–42.
  23. Komócsi A, Vorobcsuk A, Faludi R, Pintér T, Len-key Z, Költo G, Czirják L. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford). 2012;51(6):1027–36.
  24. Elhai M, Meune C, Avouac J, Kahan A, Allanore Y. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford). 2012;51(6):1017–26.
  25. Ferri C, Bernini L, Bongiorni MG, Levorato D, Viegi G, Bravi P, Contini C, Pasero G, Bombardieri S. Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients. Arthritis Rheum. 1985;28(11):1259–66.
  26. Rokas S, Mavrikakis M, Agrios N, Mylonas D, Antoniadou L, Moulopoulos S. Electrophysiologic abnormalities of cardiac function in progressive systemic sclerosis. J Electrocardiol. 1996;29(1):17–25.
  27. Roberts NK, Cabeen WR Jr, Moss J, Clements PJ, Furst DE. The prevalence of conduction defects and cardiac arrhythmias in progressive syste mic sclerosis. Ann Intern Med. 1981;94(1):38–40.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Alekperov R.T., Cheremukhina E.O., Novikova D.S., Anan’eva L.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies